Westfield Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Westfield Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,957,058	Closed	-$61.7M	–	302
2016 Q4	$61.7M	Sell	4,957,058 -1,044,911	-17%	-$12.6M	0.54%	65
2016 Q3	$82.2M	Sell	6,001,969 -4,573,669	-43%	-$45.9M	0.66%	49
2016 Q2	$78.2M	Sell	10,575,638 -529,340	-5%	-$3.97M	0.64%	50
2016 Q1	$71M	Buy	11,104,978 +1,611,520	+17%	+$9.03M	0.54%	61
2015 Q4	$59.3M	Sell	9,493,458 -140,006	-1%	-$919K	0.4%	83
2015 Q3	$56.3M	Buy	9,633,464 +470,004	+5%	+$3.62M	0.4%	87
2015 Q2	$75.8M	Sell	9,163,460 -149,175	-2%	-$1.32M	0.46%	75
2015 Q1	$76.7M	Buy	9,312,635 +999,815	+12%	+$7.39M	0.44%	75
2014 Q4	$57.1M	Buy	+8,312,820	New	+$52M	0.34%	103

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return

Westfield Capital Management's ARIA Position: Q1 2017 in Review

Westfield Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 4,957,058 shares — an estimated $61.7M sold.

Westfield Capital Management first reported a position in ARIA in Q4 2014 and held it in 9 quarters. The position peaked at $82.2M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Westfield Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Westfield Capital Management sold 4,957,058 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $61.7M.
Westfield Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 9 quarters.
Westfield Capital Management's Ariad Pharmaceuticals Inc position peaked at $82.2M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Westfield Capital Management's 13F filing for Q1 2017, filed 12 May 2017.